Option Care Health (NASDAQ:OPCH) Updates FY 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.590-1.690 for the period, compared to the consensus estimate of 1.330. The company issued revenue guidance of $5.3 billion-$5.5 billion, compared to the consensus revenue estimate of $5.3 billion.

Analysts Set New Price Targets

A number of research firms recently weighed in on OPCH. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. JPMorgan Chase & Co. lifted their target price on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, JMP Securities restated a “market outperform” rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $32.88.

Option Care Health Trading Up 1.4 %

NASDAQ:OPCH opened at $33.96 on Tuesday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market cap of $5.78 billion, a P/E ratio of 28.54, a P/E/G ratio of 2.30 and a beta of 1.35. The firm has a 50-day simple moving average of $28.92 and a 200-day simple moving average of $28.07. Option Care Health has a one year low of $21.39 and a one year high of $34.84.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.64% of the stock is owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.